Caprylhydroxamic Acid is generally usable in a properly formulated product, but it is not risk-free for seborrheic-dermatitis-prone skin. It supports product preservation rather than treating yeast on the skin, and contact allergy has been documented in selected users.

A 2025 cosmetic safety assessment supports current uses while highlighting sensitization and increased-penetration considerations. No direct human seb derm or exact-name Malassezia evidence was found. During a raw flare, stop if the finished product causes persistent burning, itching or redness.